Opendata, web and dolomites

BioMensio SIGNED

BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioMensio project word cloud

Explore the words cloud of the BioMensio project. It provides you a very rough idea of what is the project "BioMensio" about.

tools    first    provides    traffic    spin    person    finland    stage    paramedics    market    patented    virtually    suited    intoxication    drugs    injuries    understand    government    ready    fatalities    employers    biomensio    variety    exceeds    sensing    off    stringent    million    legalisation    norms    billion    alcohol    patient    deploying    drive    workplace    people    rapid    performance    accelerator    drivers    reduce    found    accidents    prevent    accuracy    centre    efficient    mass    drugged    war    inability    vtt    fuelled    designed    drug    solutions    saliva    preventative    caused    detect    machinery    levels    bio    influence    bulkiness    narcotics    sized    instrumentation    simultaneously    hampered    siemens    heavy    worldwide    globally    proof    device    mechanism    administrate    fatal    deaths    driving    helps    police    mishandling    minutes    company    backed    uncertain    platform    coming    palm    illicit    accurate    deployment    surpassed   

Project "BioMensio" data sheet

The following table provides information about the project.

Coordinator
BIOMENSIO OY 

Organization address
address: HERMIANKATU 6-8 H
city: TAMPERE
postcode: 33720
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙560˙030 €
 EC max contribution 2˙492˙021 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMENSIO OY FI (TAMPERE) coordinator 2˙492˙021.00

Map

 Project objective

In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs.

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology.

BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOMENSIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOMENSIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Proteus 25 (2018)

Developing the world’s first food wrapping machine with organic film

Read More  

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More